Diabetes awareness survey reveals alarming figures across the Middle East and Northern Africa regions

Novo NordiskIn the lead up to World Diabetes Day 2010 on 14 November Novo Nordisk and Ipsos Emirates Health conducted a survey in ten countries of the Middle East and Northern Africa (MENA) region: Algeria, Egypt, Iran, Iraq, Jordan, Lebanon, Morocco, Kingdom of Saudi Arabia (KSA), Tunisia and the United Arab Emirates (UAE).

The survey, which was carried out in October this year, assesses the level of awareness among the general population when it comes to causes, risks and complications of diabetes. It also looks into respondents' risk of developing diabetes. With over 3,000 interviews, the respondents were representative of the demographic and socio-economic profile in each country.

The survey shows that 41% of respondents are at risk of developing diabetes. Despite a high awareness level of the scale of the disease, only one in two respondents consider diabetes to be a severe or a very severe disease. Myths about diabetes also remain very common:

  • 31% of Algerian respondents believe that diabetes is contagious
  • Stress was ranked as a leading cause of diabetes across the region (39%)
  • Half of respondents (52%) declared that stroke cannot be caused by diabetes

"The results of the MENA diabetes awareness survey are striking. The need to further educate the general public about the risk factors, complications and the severity of the condition is very clear. We hope that the initiative will inspire authorities to tackle this issue. We believe that early detection of diabetes, prevention and education can make a real difference," said Lise Kingo, executive vice president and chief of staffs at Novo Nordisk.

Diabetes is sweeping the MENA region affecting an estimated 26.6 million people today, creating overwhelming demands on the region's healthcare systems and huge financial burdens on its governments. As alarming as this picture is, the number of people with diabetes is expected to double to 51.7 million people by 2030.

About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk.com.

Most Popular Now

73,000 Scientists collaborate over new COVID-19 Da…

More than 73,000 users collaborate on new online platform set up by the European Open Science Cloud Initiative, where scientists share COVID-19 data and accelerate our un...

Antiviral used to treat cat coronavirus also works…

Researchers at the University of Alberta are preparing to launch clinical trials of a drug used to cure a deadly disease caused by a coronavirus in cats that they expect ...

Search for COVID-19 drugs boosted by SARS discover…

An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19. Us...

Pfizer and BioNTech share positive early data on l…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) shared additional Phase 1 safety and immunogenicity data from their ongoing U.S. study of the BNT162 mRNA-based vac...

Phase I clinical trial initiated for monoclonal an…

The first participants have been dosed in a Phase I trial of AZD7442, a combination of two monoclonal antibodies (mAbs) in development for the prevention and treatment of...

Europe's largest initiative launches to accelerate…

CARE (Corona Accelerated R&D in Europe) a new consortium supported by the Innovative Medicines Initiative (IMI) public-private partnership announced its launch to acceler...

Vitamin D deficiency may raise risk of getting COV…

In a retrospective study of patients tested for COVID-19, researchers at the University of Chicago Medicine found an association between vitamin D deficiency and the like...

Blocking cellular communication stops SARS-CoV-2

In the transmission of signals within the cell which, for example, stimulate cell growth or trigger metabolic processes, phosphate groups play an important biochemical ro...

Improving FDA's COVID-19 vaccine authorization and…

On March 28, the Food and Drug Administration (FDA) exercised its Emergency Use Authorization (EUA) authority to allow the use of hydroxychloroquine for the treatment of ...

Steroid found to improve survival of critically il…

A new international study published today has shown that treating critically ill patients with COVID-19 with the steroid hydrocortisone improves their chances of recovery...

Bayer and Informed Data Systems Inc. (One Drop) jo…

Bayer and Informed Data Systems Inc. (One Drop), a US-based digital health company, today announced that they have entered into an agreement to jointly develop digital he...

Abbott's fast, $5, 15-minute, easy-to-use COVID-19…

Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its BinaxNOWâ„¢ COVID-19 Ag Card rapid test f...